# Regis Corp: financial statements, quarterly

RGS · Nasdaq · CIK 716643 · [Industrials](/sectors/industrials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/rgs.md) · [Financials](/companies/rgs/financials.md) · [Filings](/companies/rgs/filings.md) · [Insiders](/companies/rgs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rgs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [53.4](/filings/0000716643-24-000032.md) | [51.1](/filings/0000716643-25-000010.md) | [49.2](/filings/0000716643-25-000021.md) | [49.4 d](/filings/0000716643-26-000031.md) | [46.1](/filings/0000716643-25-000041.md) | [46.7](/filings/0000716643-26-000006.md) | [57.0](/filings/0000716643-26-000023.md) | [60.4 d](/filings/0000716643-26-000031.md) | [59.0](/filings/0000716643-25-000041.md) | [57.1](/filings/0000716643-26-000006.md) | [52.4](/filings/0000716643-26-000023.md) | [56.0 d](/filings/0000716643-26-000031.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [7.4](/filings/0000716643-24-000032.md) | [4.8](/filings/0000716643-25-000010.md) | [4.1](/filings/0000716643-25-000021.md) | [4.6 d](/filings/0000716643-26-000031.md) | [2.1](/filings/0000716643-25-000041.md) | [5.5](/filings/0000716643-26-000006.md) | [5.0](/filings/0000716643-26-000023.md) | [7.3 d](/filings/0000716643-26-000031.md) | [5.9](/filings/0000716643-25-000041.md) | [6.2](/filings/0000716643-26-000006.md) | [5.7](/filings/0000716643-26-000023.md) | [6.6 d](/filings/0000716643-26-000031.md) |
| Interest expense | $m | [6.2](/filings/0000716643-24-000032.md) | [6.2](/filings/0000716643-25-000010.md) | [6.2](/filings/0000716643-25-000021.md) | [6.9 d](/filings/0000716643-26-000031.md) | [4.8](/filings/0000716643-25-000041.md) | [4.8](/filings/0000716643-26-000006.md) | [5.1](/filings/0000716643-26-000023.md) | [5.5 d](/filings/0000716643-26-000031.md) | [5.3](/filings/0000716643-25-000041.md) | [5.3](/filings/0000716643-26-000006.md) | [5.0](/filings/0000716643-26-000023.md) | [5.1 d](/filings/0000716643-26-000031.md) |
| Income tax | $m | [(0.1)](/filings/0000716643-24-000032.md) | [(0.1)](/filings/0000716643-25-000010.md) | [0.1](/filings/0000716643-25-000021.md) | [1.1 d](/filings/0000716643-26-000031.md) | [(0.2)](/filings/0000716643-25-000041.md) | [0.1](/filings/0000716643-26-000006.md) | [(0.0)](/filings/0000716643-26-000023.md) | [(115) d](/filings/0000716643-26-000031.md) | [0.5](/filings/0000716643-25-000041.md) | [1.0](/filings/0000716643-26-000006.md) | [0.2](/filings/0000716643-26-000023.md) | [(2.8) d](/filings/0000716643-26-000031.md) |
| Net income | $m | [1.2](/filings/0000716643-24-000032.md) | [1.0](/filings/0000716643-25-000010.md) | [(2.3)](/filings/0000716643-25-000021.md) | [91.2 d](/filings/0000716643-26-000031.md) | [(0.9)](/filings/0000716643-25-000041.md) | [7.6](/filings/0000716643-26-000006.md) | [0.3](/filings/0000716643-26-000023.md) | [116 d](/filings/0000716643-26-000031.md) | [1.4](/filings/0000716643-25-000041.md) | [0.5](/filings/0000716643-26-000006.md) | [0.7](/filings/0000716643-26-000023.md) | [4.4 d](/filings/0000716643-26-000031.md) |
| Diluted EPS | $ per share | [0.51](/filings/0000716643-24-000032.md) | [0.43](/filings/0000716643-25-000010.md) | [(1.00)](/filings/0000716643-25-000021.md) | not reported | [(0.36)](/filings/0000716643-25-000041.md) | [2.71](/filings/0000716643-26-000006.md) | [0.08](/filings/0000716643-26-000023.md) | not reported | [0.49](/filings/0000716643-25-000041.md) | [0.16](/filings/0000716643-26-000006.md) | [0.26](/filings/0000716643-26-000023.md) | not reported |
| Basic EPS | $ per share | [0.51](/filings/0000716643-24-000032.md) | [0.43](/filings/0000716643-25-000010.md) | [(1.00)](/filings/0000716643-25-000021.md) | not reported | [(0.36)](/filings/0000716643-25-000041.md) | [3.29](/filings/0000716643-26-000006.md) | [0.10](/filings/0000716643-26-000023.md) | not reported | [0.56](/filings/0000716643-25-000041.md) | [0.18](/filings/0000716643-26-000006.md) | [0.29](/filings/0000716643-26-000023.md) | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.3](/filings/0000716643-23-000044.md) | [7.2](/filings/0000716643-24-000008.md) | [5.9](/filings/0000716643-24-000020.md) | [10.1](/filings/0000716643-25-000031.md) | [6.3](/filings/0000716643-24-000032.md) | [10.2](/filings/0000716643-25-000010.md) | [13.3](/filings/0000716643-25-000021.md) | [17.0](/filings/0000716643-26-000031.md) | [16.6](/filings/0000716643-25-000041.md) | [18.4](/filings/0000716643-26-000006.md) | [22.9](/filings/0000716643-26-000023.md) | [26.0](/filings/0000716643-26-000031.md) |
| Current assets | $m | [34.6](/filings/0000716643-23-000044.md) | [35.4](/filings/0000716643-24-000008.md) | [27.8](/filings/0000716643-24-000020.md) | [42.1](/filings/0000716643-25-000031.md) | [35.4](/filings/0000716643-24-000032.md) | [43.4](/filings/0000716643-25-000010.md) | [47.4](/filings/0000716643-25-000021.md) | [50.5](/filings/0000716643-26-000031.md) | [51.4](/filings/0000716643-25-000041.md) | [52.1](/filings/0000716643-26-000006.md) | [54.3](/filings/0000716643-26-000023.md) | [57.4](/filings/0000716643-26-000031.md) |
| Total assets | $m | [580](/filings/0000716643-23-000044.md) | [574](/filings/0000716643-24-000008.md) | [544](/filings/0000716643-24-000020.md) | [530](/filings/0000716643-25-000031.md) | [509](/filings/0000716643-24-000032.md) | [530](/filings/0000716643-25-000010.md) | [511](/filings/0000716643-25-000021.md) | [599](/filings/0000716643-26-000031.md) | [592](/filings/0000716643-25-000041.md) | [588](/filings/0000716643-26-000006.md) | [557](/filings/0000716643-26-000023.md) | [547](/filings/0000716643-26-000031.md) |
| Current liabilities | $m | [117](/filings/0000716643-23-000044.md) | [115](/filings/0000716643-24-000008.md) | [109](/filings/0000716643-24-000020.md) | [104](/filings/0000716643-25-000031.md) | [101](/filings/0000716643-24-000032.md) | [108](/filings/0000716643-25-000010.md) | [101](/filings/0000716643-25-000021.md) | [102](/filings/0000716643-26-000031.md) | [100.0](/filings/0000716643-25-000041.md) | [98.1](/filings/0000716643-26-000006.md) | [91.7](/filings/0000716643-26-000023.md) | [91.9](/filings/0000716643-26-000031.md) |
| Total liabilities | $m | [615](/filings/0000716643-23-000044.md) | [607](/filings/0000716643-24-000008.md) | [580](/filings/0000716643-24-000020.md) | [474](/filings/0000716643-25-000031.md) | [453](/filings/0000716643-24-000032.md) | [463](/filings/0000716643-25-000010.md) | [443](/filings/0000716643-25-000021.md) | [413](/filings/0000716643-26-000031.md) | [405](/filings/0000716643-25-000041.md) | [400](/filings/0000716643-26-000006.md) | [367](/filings/0000716643-26-000023.md) | [353](/filings/0000716643-26-000031.md) |
| Long-term debt | $m | [180](/filings/0000716643-23-000044.md) | [182](/filings/0000716643-24-000008.md) | [180](/filings/0000716643-24-000020.md) | [99.5](/filings/0000716643-25-000031.md) | [95.2](/filings/0000716643-24-000032.md) | [112](/filings/0000716643-25-000010.md) | [112](/filings/0000716643-25-000021.md) | [110](/filings/0000716643-26-000031.md) | [110](/filings/0000716643-25-000041.md) | [111](/filings/0000716643-26-000006.md) | [113](/filings/0000716643-26-000023.md) | [114](/filings/0000716643-26-000031.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [0.0](/filings/0000716643-25-000031.md) | not reported | not reported | not reported | [1.1](/filings/0000716643-26-000031.md) | [1.7](/filings/0000716643-25-000041.md) | [2.1](/filings/0000716643-26-000006.md) | [2.6](/filings/0000716643-26-000023.md) | [3.0](/filings/0000716643-26-000031.md) |
| Shareholders' equity | $m | [(35.3)](/filings/0000716643-25-000010.md) | [(33.6)](/filings/0000716643-25-000021.md) | [(35.8)](/filings/0000716643-25-000021.md) | [56.8](/filings/0000716643-26-000031.md) | [56.4](/filings/0000716643-26-000006.md) | [66.7](/filings/0000716643-26-000023.md) | [68.6](/filings/0000716643-26-000023.md) | [186](/filings/0000716643-26-000031.md) | [188](/filings/0000716643-26-000006.md) | [189](/filings/0000716643-26-000023.md) | [189](/filings/0000716643-26-000023.md) | [194](/filings/0000716643-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,824)](/filings/0000716643-24-000032.md) | [(4,029) d](/filings/0000716643-25-000010.md) | [(277) d](/filings/0000716643-25-000021.md) | [5,090 d](/filings/0000716643-26-000031.md) | [(1,344)](/filings/0000716643-25-000041.md) | [2,131 d](/filings/0000716643-26-000006.md) | [6,199 d](/filings/0000716643-26-000023.md) | [6,758 d](/filings/0000716643-26-000031.md) | [2,283](/filings/0000716643-25-000041.md) | [1,663 d](/filings/0000716643-26-000006.md) | [4,972 d](/filings/0000716643-26-000023.md) | [4,185 d](/filings/0000716643-26-000031.md) |
| Capital expenditure | $k | [163](/filings/0000716643-24-000032.md) | [160 d](/filings/0000716643-25-000010.md) | [49.0 d](/filings/0000716643-25-000021.md) | [4.0 d](/filings/0000716643-26-000031.md) | [16.0](/filings/0000716643-25-000041.md) | [428 d](/filings/0000716643-26-000006.md) | [325 d](/filings/0000716643-26-000023.md) | [526 d](/filings/0000716643-26-000031.md) | [395](/filings/0000716643-25-000041.md) | [772 d](/filings/0000716643-26-000006.md) | [216 d](/filings/0000716643-26-000023.md) | [590 d](/filings/0000716643-26-000031.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.1](/filings/0000716643-23-000044.md) | [2.3](/filings/0000716643-24-000008.md) | [2.3](/filings/0000716643-24-000020.md) | [2.4](/filings/0000716643-24-000032.md) | [2.3](/filings/0000716643-25-000010.md) | [2.3](/filings/0000716643-25-000021.md) | [2.3](/filings/0000716643-25-000041.md) | [2.8](/filings/0000716643-26-000006.md) | [3.0](/filings/0000716643-26-000023.md) | [2.8](/filings/0000716643-25-000041.md) | [2.9](/filings/0000716643-26-000006.md) | [2.9](/filings/0000716643-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,498,778 at 2026-08-25, from the cover of the [10-K filed 2026-09-01](/filings/0000716643-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.